- 04 June | MGP Strategy Series | GS Paper 4 (Ethics) with AIR 7 A.R. Rajah Mohaideen Click Here to register for the session →
- 04 June | GS Advance Program begins from 4th June 2026 | First 2 classes open to all Click Here to register for the event →
- 05 June | MGP Strategy Series | GS Paper 3 Strategy Session with AIR 406 Mannat Luthra Click Here to register for the session
- 06 June | Open Orientation on Essay Guidance Program (EGP 2026) Click Here to register →
- 07 June | Open Orientation for Current Affairs for Mains 2026 Click Here to register →
- 07 June | Sociology Optional Strategy Session with AIR 10 Ujjwal Priyank Click Here to register →
Source: The post is based on the article “Welcome happening: Robust institutional mechanisms must be in place for human challenge studies” published in “The Hindu” on 26th July 2023.
Syllabus: GS2- Issues relating to development and management of Social Sector/Services relating to Health, Education & GS4- compassion towards the weaker-sections.
News: The author discusses the need for strong institutional mechanisms and ethical considerations before conducting human challenge studies (CHIS) in India.
What are Human Challenge Studies (CHIS)?
Definition of CHIS: Human Challenge Studies (CHIS) involve intentionally exposing healthy volunteers to disease-causing microbes in a controlled environment for research purposes.
Purpose of CHIS: CHIS aims to study various facets of infections and diseases, test medical interventions, and accelerate vaccine development.
What are the benefits of CHIS?
Faster Vaccine Development: CHIS can accelerate vaccine development by providing critical data on immune responses and safety, reducing the need for large phase-3 trials.
Understanding Infections: CHIS helps researchers gain valuable insights into the various facets of infections and diseases, aiding in the development of effective treatments.
Controlled Environment: CHIS allows for the study of diseases in a controlled and monitored setting, minimizing risks to the wider population.
Cost-Effectiveness: CHIS can potentially reduce the cost and time required for vaccine development.
What are the challenges of CHIS?
Ethical Concerns: CHIS raises ethical issues related to the intentional exposure of healthy volunteers to disease-causing microbes.
Potential for Exploitation: Monetary incentives involved in CHIS may lead to the exploitation of volunteers.
Robust Institutional Mechanisms: Conducting CHIS requires well-trained personnel and strong institutional structures.
Previous Ethical Violations: Instances like the HPV vaccine trial in Andhra Pradesh (2010) highlight the importance of stringent oversight.
Limited Medical Intervention: CHIS may be unsuitable for studying novel diseases with limited medical interventions.
